Results 11 to 20 of about 458,168 (201)

What is the status of immunotherapy in thyroid neoplasms? [PDF]

Frontiers in Endocrinology, 2022
Immunotherapy has changed the treatment of patients with advanced cancer, with different phase III trials showing durable responses across different histologies.
Alejandro Garcia-Alvarez, Jorge Hernando, Ana Carmona-Alonso, Jaume Capdevila   +3 more
doaj   +4 more sources

Subclassification of Follicular Neoplasms Recommended by the Japan Thyroid Association Reporting System of Thyroid Cytology [PDF]

International Journal of Endocrinology, 2015
Background. The Japan Thyroid Association recently published guidelines for clinical practice for the management of thyroid nodules, which include a diagnostic system for reporting thyroid fine needle aspiration cytology.
Kennichi Kakudo, Kaori Kameyama, Mitsuyoshi Hirokawa, Ryohei Katoh, Hirotoshi Nakamura   +4 more
doaj   +2 more sources

Long noncoding RNA landscapes specific to benign and malignant thyroid neoplasms of distinct histological subtypes [PDF]

Scientific Reports, 2021
The main types of thyroid neoplasms, follicular adenoma (FA), follicular thyroid carcinoma (FTC), classical and follicular variants of papillary carcinoma (clPTC and fvPTC), and anaplastic thyroid carcinoma (ATC), differ in prognosis, progression rate ...
Valentina D. Yakushina, Vladimir V. Strelnikov, Alexander S. Tanas, Alexander V. Lavrov   +3 more
doaj   +2 more sources

Diagnostic challenges in the assessment of thyroid neoplasms using nuclear features and vascular and capsular invasion: a multi-center interobserver agreement study [PDF]

Journal of Pathology and Translational Medicine
Background The diagnosis of thyroid neoplasms necessitates the identification of distinct histological features. Various education/hospital centers located in cities across Indonesia likely result in discordances among pathologists when diagnosing ...
Agnes Stephanie Harahap, Mutiah Mutmainnah, Maria Francisca Ham, Dina Khoirunnisa, Abdillah Hasbi Assadyk, Husni Cangara, Aswiyanti Asri, Diah Prabawati Retnani, Fairuz Quzwain, Hasrayati Agustina, Hermawan Istiadi, Indri Windarti, Krisna Murti, Muhammad Takbir, Ni Made Mahastuti, Nila Kurniasari, Nungki Anggorowati, Pamela Abineno, Yulita Pundewi Setyorini, Kennichi Kakudo   +19 more
doaj   +2 more sources

Immunohistochemical Expression of HBME-1 in a Spectrum of Thyroid Neoplasms [PDF]

Indian Journal of Endocrinology and Metabolism
Introduction: Thyroid neoplasms are the most common malignancy of the endocrine system, representing 3.8% of new cancer cases, and it is the ninth most common cancer overall.
Archi A. Chawla, Reeta Dhar, Shilpi Sahu
doaj   +2 more sources

Aggressive Types of Malignant Thyroid Neoplasms. [PDF]

J Clin Med
Differentiated thyroid cancer (DTC) includes many subtypes, which demonstrate favorable to aggressive behavior. During the past decades, efforts have been made to describe aggressive thyroid cancers.
Boudina M, Zisimopoulou E, Xirou P, Chrisoulidou A.   +3 more
europepmc   +2 more sources

Proteomic and Postproteomic Characterization of Keratan Sulfate-Glycanated Isoforms of Thyroglobulin and Transferrin Uniquely Elaborated by Papillary Thyroid Carcinomas. [PDF]

, 2003
Previous studies have suggested that surface components of papillary thyroid carcinoma (PTC) cells may be aberrantly glycanated, but the precise nature of these molecules has not been unveiled nor documented to be of clinical relevance.
Goletz, Steffen, Colombatti, Alfonso, Bisceglia, Michele, Perissinotto, Daniela, Magro, Gaetano, Brown, Gavin, Grasso, Sebastiano, Müller, Eva-Christina, Ellis, Timothy, Otto, Albrecht, Perris, Roberto, Schiappacassi, Monica   +11 more
core   +4 more sources

Morphological features of thyroid benign focal neoplasms in Graves’ disease

Mìžnarodnij Endokrinologìčnij Žurnal, 2022
Background. The morphology of the thyroid in Graves’ disease (GD) can be quite diverse: in most cases there is a diffuse enlargement of the thyroid gland (diffuse goiter), in some cases it is not increased, and in some patients there are focal neoplasms (
Yu.V. Buldygina, A.V. Zelinskaya, L.Yu. Zurnadzhy, Yu.M. Tarashchenko, S.L. Shlyakhtych, M.D. Tronko   +5 more
doaj   +1 more source

Combined Cyclin D2 and Protein Convertase 2 Genes in Differentiating Various Follicularpatterned Lesions and Neoplasms of the Thyroid: A Cross-sectional Study [PDF]

Journal of Clinical and Diagnostic Research, 2023
Introduction: A pretherapeutic distinction between benign and malignant thyroid nodules is critical for the clinical management of patients presenting with thyroid nodules.
Prasanna Venkadesa Perumal, Neelaiah Siddaraju, Sunil Kumar Saxen, Soundravally rajendiran, Ramachandra V Bhat   +4 more
doaj   +1 more source

Study of nuclear morphometry in the cytologic evaluation of thyroid neoplasms

Journal of Pathology of Nepal, 2023
Background: Nuclear morphometry is purported to allow better differentiation between various thyroid lesions beyond what is offered by conventional cytology.
Joyce Thomas, Tulsi Shyam Chhadi, Hirkani Chhadi   +2 more
doaj   +1 more source